Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript


Image source: The Motley Fool.

Karyopharm Therapeutics (NASDAQ: KPTI)
Q1 2024 Earnings Call
May 08, 2024, 8:00 a.m. ET

Operator

Continue reading


Source Fool.com

Karyopharm Therapeutics Inc. Stock

€0.86
-4.040%
Karyopharm Therapeutics Inc. took a tumble today and lost -€0.037 (-4.040%).
We see a rather positive sentiment for Karyopharm Therapeutics Inc. with 9 Buy predictions and 2 Sell predictions.
With a target price of 7 € there is potential for a 716.8% increase which would mean more than doubling the current price of 0.86 € for Karyopharm Therapeutics Inc..
Like: 0
Share

Comments